SCHEMBL6701157

SCHEMBL6701157

COc1cc(OCc2ccccc2)cc(OC)c1-c1c(OC)cc(OCc2ccccc2)cc1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.61
PDGFRB P09619 1/20 0.55
PDGFRA P16234 1/20 0.55
GAA P10253 4/20 0.52
MGAM O43451 3/20 0.52
SI P14410 3/20 0.52
MGAM2 Q2M2H8 3/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALOX5 P09917 1/20 0.50
ALDH1A1 P00352 2/20 0.49
MAPT P10636 2/20 0.49
ALOX12 P18054 2/20 0.49
LMNA P02545 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HTR1A P08908 2/20 0.49
ADRA1D P25100 1/20 0.49
ADRA1A P35348 1/20 0.49
ADRA1B P35368 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27998563 0.87 MAOB (0.59) MAOBPDGFRBPDGFRAGAAMGAM
SCHEMBL25282560 0.86 MAOB (0.57) MAOBPDGFRBPDGFRAGAAMEN1
SCHEMBL6696628 0.86 MAOB (0.57) MAOBPDGFRBPDGFRAGAAMEN1
SCHEMBL2094271 0.84 MAOB (0.59) MAOBPDGFRBPDGFRAGAAMGAM
SCHEMBL4599002 0.83 MAOB (0.54) MAOBPDGFRBPDGFRAGAAMEN1
SCHEMBL23906959 0.82 MAOB (0.79) MAOBGAAMEN1KMT2AALOX5
SCHEMBL18623122 0.82 MAOB (0.62) MAOBPDGFRBPDGFRAMEN1KMT2A
SCHEMBL2090976 0.82 MAOB (0.62) MAOBPDGFRBPDGFRAKMT2AALOX5
SCHEMBL1745424 0.82 MAOB (0.53) MAOBPDGFRBPDGFRAMEN1KMT2A
SCHEMBL10665635 0.82 MAOB (0.53) MAOBPDGFRBPDGFRAGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147597-A1 Anti-mycobacterium compositions and methods of preparing and using same ADVANCED LIFE SCIENCES, INC. 2004-07-29 US disclosed
US-6677350-B1 ADMINISTERING CHALCONE-LIKE VINYLCARBONYL COMPOUNDS TO PREVENT OR TREAT MYCOBACTERIUM INFECTIONS/TUBERCULOSIS ADVANCED LIFE SCIENCES, INC. 2004-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147597-A1 Anti-mycobacterium compositions and methods of preparing and using same IMMT, CYP51A1, LSS MAOB 1715/4885PDGFRB 4749/4885PDGFRA 4816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.